Bunkerhill MAC vs LINQ II Insertable Cardiac Monitor
AI Verdict
Choose Bunkerhill MAC if…
Choose Bunkerhill MAC if your primary goal is to proactively identify patients at increased cardiovascular risk by leveraging existing routine, non-gated chest CT scans. This tool is ideal for health systems looking to automate the detection and quantification of mitral annular calcification (MAC) to facilitate early intervention and streamline care coordination through an integrated AI platform.
View Bunkerhill MAC →Choose LINQ II Insertable Cardiac Monitor if…
Choose the Medtronic LINQ II if you require long-term, continuous heart rhythm monitoring to diagnose infrequent or symptomatic arrhythmias that are difficult to capture with conventional methods. This insertable cardiac monitor is best suited for patients needing extended surveillance, offering AI-powered accuracy and remote management capabilities for comprehensive arrhythmia detection.
View LINQ II Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill MAC | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Pricing | Contact for pricing | Enterprise |
| Deployment | Cloud-based, integrated with existing EHRs and clinical systems via Carebricks platform. | Hybrid |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Bunkerhill MACBunkerhill MAC emphasizes seamless integration with existing EHRs and clinical systems, analyzing routine CT scans without disrupting current workflows. This focus on passive, integrated clinician use within familiar environments makes it highly usable for healthcare providers. In contrast, LINQ II involves an implanted device and patient interaction with a mobile app, introducing a different layer of usability considerations for patients rather than purely clinician workflow.
Clinical Value
LINQ II Insertable Cardiac MonitorMedtronic LINQ II offers long-term, continuous heart rhythm monitoring for up to 4.5 years, with enhanced AI accuracy for diagnosing arrhythmias and a pediatric indication. This provides sustained diagnostic utility across a broader patient population. While Bunkerhill MAC offers significant value in early cardiovascular risk identification from existing scans, LINQ II's continuous, long-term diagnostic capability for a range of arrhythmias presents a wider and deeper clinical impact.
Pricing & Value
TieBoth tools operate on an enterprise pricing model that is not publicly disclosed, requiring direct contact for quotes. Without specific pricing details or transparent value propositions, it is impossible to conduct a meaningful comparison or determine which offers superior value. Therefore, this dimension is a tie.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorMedtronic LINQ II demonstrates superior enterprise readiness with explicit HIPAA compliance, FDA clearance, a hybrid deployment model, and a proven track record with over a million patients worldwide. As a global medical device leader, Medtronic offers established infrastructure and trust. Bunkerhill MAC, while FDA-cleared, is less explicit about its full compliance details and has a less documented enterprise footprint.
Innovation
Bunkerhill MACBunkerhill MAC stands out for its use of 'Generative AI for clinical reasoning and action' to detect and quantify mitral annular calcification on routine, non-gated CT scans. This application of generative AI to extract novel, clinically significant insights from existing imaging data represents a more cutting-edge and transformative approach. While LINQ II features advanced AI for enhanced accuracy and innovative PVC detection, it primarily refines an existing device category.
Support & Docs
LINQ II Insertable Cardiac MonitorMedtronic LINQ II provides extensive support and documentation, including detailed clinician manuals, patient education brochures, FAQs, and dedicated technical and patient support phone lines. In contrast, Bunkerhill Health's publicly available information primarily focuses on compliance and security reports, lacking readily accessible user-facing product support or documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill MAC | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Name | Bunkerhill MAC | LINQ II Insertable Cardiac Monitor |
| Company | Bunkerhill Health | Medtronic |
| Description | Bunkerhill MAC is an FDA-cleared AI algorithm by Bunkerhill Health that detects and quantifies mitral annular calcification (MAC) on routine CT scans, aiding early cardiovascular risk identification and care coordination within the Carebricks platform. | The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. |
| Key Features | AI-powered detection and quantification of Mitral Annular Calcification (MAC); Analyzes routine, non-gated chest CT scans; Identifies patients at increased cardiovascular risk; Integrates with the Carebricks generative AI platform for clinical reasoning and action; Supports automated workflows for follow-up and care coordination; Developed and validated through a multi-institutional research consortium; Seamless integration with existing EHRs and clinical systems | AccuRhythmu2122 AI algorithms for enhanced accuracy; Remote programming capability; Up to 4.5 years of continuous monitoring; MRI compatibility (1.5 and 3.0T); MyCareLink Heartu2122 mobile app for data transmission; MyCareLink Relayu2122 home communicator option; Innovative PVC detection algorithm; Pediatric indication (ages 2+) |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill MAC and LINQ II Insertable Cardiac Monitor.